Correspondence Activity Detail
RenovoRx, Inc. (RNXT)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 23, 2026 | CORRESP | Neutral/Informational | Moderate | RenovoRx, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3, which was filed on April 16, 2026. The com… | Read Filing EDGAR |
| Apr. 22, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated April 22, 2026, informs Shaun Bagai, CEO of RenovoRx, Inc., that the SEC has not reviewed and will not review their registration statement filed on Ap… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.